CORSENSE
DEAD

Serial Number

79425407

Owner

CorSense GmbH

Filing Date

Feb 27, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CORSENSE Trademark

Serial Number: 79425407

CORSENSE is a trademark filed by CorSense GmbH on February 27, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

CorSense GmbH

Waldstraße 14

Entity Type: 98

Trademark Details

Filing Date

February 27, 2025

Registration Date

Not Registered

Goods & Services

Surgical, medical, and veterinary apparatus and instruments, namely, surgical or medical devices for treating or diagnose structural heart diseases, surgical or medical devices for treating heart failure, surgical or medical devices for providing endovascular therapy and open heart surgery, heart and lung assist devices, pressure and flow sensors, catheters, stents such as coated stents or self-expanding stents, obliteration devices, occlusion devices, implantable ventricular devices, cannulas; Suture materials; Catheters, in particular balloon catheters; Medical apparatus and instruments for treating structural heart disease; Medical devices to treat heart failure; Medical devices for endovascular therapy; Medical devices for open surgery; Heart and lung support devices, pressure and flow sensors , namely, stents, lung ventilators, implantable ventricular assist devices such as implantable left or right ventricular assist devices, permanent implantable ventricular assist devices; Stents in particular coated stents or self-expanding stents; Obliteration devices, namely, left atrial appendage (LAA) obliteration devices, surgical devices that facilitate the identification, separation or ablation of biologic tissues; Occlusion devices, namely, catheters, stents, patent foramen ovale (PFO) occlusion devices; atrial septal defect (ASD) occlusion devices; ventricular septal defect (VSD) occlusion devices; Implantable ventricular devices, namely intravascular implants comprised of artificial material or implantable ventricular assist devices; Cannulae.

Pharmaceuticals and veterinary preparations for the treatment of cardiovascular diseases, heart and circulatory diseases, heart failure, coronary diseases, endovascular diseases, structural heart diseases.

Medical services.

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 3, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 3, 2026 ABN2
REFUSAL PROCESSED BY IB
Oct 3, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 18, 2025 RFCS
REFUSAL PROCESSED BY MPU
Sep 18, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 8, 2025 RFCR
NON-FINAL ACTION WRITTEN
Aug 7, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 31, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 6, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 6, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 5, 2025 REPR